» Articles » PMID: 32585303

Post-translational Modifications of S1PR1 and Endothelial Barrier Regulation

Overview
Publisher Elsevier
Date 2020 Jun 26
PMID 32585303
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Sphingosine-1-phosphate receptor-1 (S1PR1), a G-protein coupled receptor that is expressed in endothelium and activated upon ligation by the bioactive lipid sphingosine-1-phosphate (S1P), is an important vascular-barrier protective mechanism at the level of adherens junctions (AJ). Loss of endothelial barrier function is a central factor in the pathogenesis of various inflammatory conditions characterized by protein-rich lung edema formation, such as acute respiratory distress syndrome (ARDS). While several S1PR1 agonists are available, the challenge of arresting the progression of protein-rich edema formation remains to be met. In this review, we discuss the role of S1PRs, especially S1PR1, in regulating endothelial barrier function. We review recent findings showing that replenishment of the pool of cell-surface S1PR1 may be crucial to the effectiveness of S1P in repairing the endothelial barrier. In this context, we discuss the S1P generating machinery and mechanisms that regulate S1PR1 at the cell surface and their impact on endothelial barrier function.

Citing Articles

The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.

Wang W, Zhao Y, Zhu G Front Cell Neurosci. 2024; 17:1288437.

PMID: 38179204 PMC: 10764561. DOI: 10.3389/fncel.2023.1288437.


Sphingosine-1-Phosphate Receptor 3 Induces Endothelial Barrier Loss via ADAM10-Mediated Vascular Endothelial-Cadherin Cleavage.

Wu J, Liang Y, Fu P, Feng A, Lu Q, Unwalla H Int J Mol Sci. 2023; 24(22).

PMID: 38003272 PMC: 10671260. DOI: 10.3390/ijms242216083.


Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner.

Baoyinna B, Miao J, Oliver P, Ye Q, Shaheen N, Kalin T Biomedicines. 2023; 11(9).

PMID: 37760892 PMC: 10525432. DOI: 10.3390/biomedicines11092451.


Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury.

Sun G, Wang B, Zhu H, Ye J, Liu X Front Med (Lausanne). 2023; 10:1265398.

PMID: 37746079 PMC: 10514503. DOI: 10.3389/fmed.2023.1265398.


S1P/S1PR signaling pathway advancements in autoimmune diseases.

Li J, Huang Y, Zhang Y, Liu P, Liu M, Zhang M Biomol Biomed. 2023; 23(6):922-935.

PMID: 37504219 PMC: 10655875. DOI: 10.17305/bb.2023.9082.


References
1.
Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A . Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J. 2000; 352 Pt 3:809-15. PMC: 1221521. View

2.
Timmerman I, Hoogenboezem M, Bennett A, Geerts D, Hordijk P, van Buul J . The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation. Mol Biol Cell. 2012; 23(21):4212-25. PMC: 3484100. DOI: 10.1091/mbc.E12-01-0038. View

3.
Siow D, Anderson C, Berdyshev E, Skobeleva A, Pitson S, Wattenberg B . Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate. J Lipid Res. 2010; 51(9):2546-59. PMC: 2918438. DOI: 10.1194/jlr.M004374. View

4.
Bergelin N, Lof C, Balthasar S, Kalhori V, Tornquist K . S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. Endocrinology. 2010; 151(7):2994-3005. DOI: 10.1210/en.2009-1387. View

5.
Burg N, Swendeman S, Worgall S, Hla T, Salmon J . Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury. Arthritis Rheumatol. 2018; 70(11):1879-1889. PMC: 6734184. DOI: 10.1002/art.40558. View